1. Home
  2. NVCT
  3. NVCT News

Latest Nuvectis Pharma Inc. (NVCT) News on July 2, 2025

Insiders of Nuvectis Pharma, Inc. (NASDAQ:NVCT) must be disappointed as stock fell 10% after recent purchases
NVCT

Simply Wall St.

14 days ago

Insiders of Nuvectis Pharma, Inc. (NASDAQ:NVCT) must be disappointed as stock fell 10% after recent purchases

Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect?
NVCT

Zacks

2 months ago

Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect?

Nuvectis Pharma (NASDAQ:NVCT) Is In A Good Position To Deliver On Growth Plans
NVCT

Simply Wall St.

2 months ago

Nuvectis Pharma (NASDAQ:NVCT) Is In A Good Position To Deliver On Growth Plans

Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights
NVCT

GlobeNewswire

2 months ago

Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

Why Nuvectis Pharma, Inc. (NVCT) is Surging in 2025
NVCT

Insider Monkey

2 months ago

Why Nuvectis Pharma, Inc. (NVCT) is Surging in 2025

Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting
NVCT

GlobeNewswire

2 months ago

Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting

NVCT

MT Newswires

3 months ago

Maxim Initiates Nuvectis Pharma at Buy With $17 Price Target

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting
NVCT

GlobeNewswire

3 months ago

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research Meeting

Nuvectis Pharma to Participate in the 37th Annual Roth Conference
NVCT

GlobeNewswire

4 months ago

Nuvectis Pharma to Participate in the 37th Annual Roth Conference

NVCT

Business Wire

4 months ago

Market News Alert: Nuvectis Pharma’s NXP900 Demonstrates Superior Efficacy in NSCLC When Combined with Tagrisso in Cleveland Clinic Study, Following New Buy Recommendation

Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC
NVCT

GlobeNewswire

4 months ago

Nuvectis Pharma Announces a New Publication of a Research Study Demonstrating that the Combination of NXP900 and EGFR Inhibitors Improves the Efficacy of the EGFR Inhibitors in Preclinical Models of EGFR Mutated NSCLC

NVCT

Business Wire

4 months ago

Market News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital Markets

Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights
NVCT

GlobeNewswire

4 months ago

Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights

NVCT

MT Newswires

5 months ago

Nuvectis Pharma Insider Bought Shares Worth $1,200,000, According to a Recent SEC Filing

NVCT

MT Newswires

5 months ago

Nuvectis Pharma Closes Stock Offering, Says Underwriter Exercised Overallotment Option

Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option
NVCT

GlobeNewswire

5 months ago

Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter’s Over-Allotment Option

NVCT

MT Newswires

5 months ago

Nuvectis Pharma Prices $13.5 Million Public Offering of Shares

Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
NVCT

GlobeNewswire

5 months ago

Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock

Nuvectis Pharma Announces Proposed Public Offering of Common Stock
NVCT

GlobeNewswire

5 months ago

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

Favourable Signals For Nuvectis Pharma: Numerous Insiders Acquired Stock
NVCT

Simply Wall St.

5 months ago

Favourable Signals For Nuvectis Pharma: Numerous Insiders Acquired Stock

Insiders hold 63% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and they've been buying recently
NVCT

Simply Wall St.

6 months ago

Insiders hold 63% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and they've been buying recently

Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium
NVCT

GlobeNewswire

7 months ago

Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium

Nuvectis Pharma (NVCT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
NVCT

Zacks

7 months ago

Nuvectis Pharma (NVCT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Nuvectis Pharma reports data from Phase 1b study of NXP800
NVCT

TipRanks

8 months ago

Nuvectis Pharma reports data from Phase 1b study of NXP800

Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug
NVCT

Benzinga

8 months ago

Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug

NVCT

MT Newswires

8 months ago

Nuvectis Pharma Says Trial of Cancer Drug NXP800 Demonstrates Tumor Shrinkage

Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer
NVCT

GlobeNewswire

8 months ago

Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer

Nuvectis Pharma (NVCT) Is a Great Choice for 'Trend' Investors, Here's Why
NVCT

Zacks

8 months ago

Nuvectis Pharma (NVCT) Is a Great Choice for 'Trend' Investors, Here's Why

Wall Street Analysts Predict a 169.94% Upside in Nuvectis Pharma (NVCT): Here's What You Should Know
NVCT

Zacks

8 months ago

Wall Street Analysts Predict a 169.94% Upside in Nuvectis Pharma (NVCT): Here's What You Should Know

Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights
NVCT

GlobeNewswire

8 months ago

Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update
NVCT

Business Wire

8 months ago

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2024 AACR-NCI-EORTC Symposium on Molecular Targets and Cancer Therapeutics
NVCT

GlobeNewswire

8 months ago

Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2024 AACR-NCI-EORTC Symposium on Molecular Targets and Cancer Therapeutics

Nuvectis Pharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
NVCT

GlobeNewswire

9 months ago

Nuvectis Pharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Here's Why We're Watching Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Situation
NVCT

Simply Wall St.

9 months ago

Here's Why We're Watching Nuvectis Pharma's (NASDAQ:NVCT) Cash Burn Situation

PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch
NVCT

Business Wire

10 months ago

PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch

Nuvectis Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference
NVCT

GlobeNewswire

10 months ago

Nuvectis Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Nuvectis’ NXP800 gains FDA ODD for cancer treatment
NVCT

Pharmaceutical Technology

10 months ago

Nuvectis’ NXP800 gains FDA ODD for cancer treatment

Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
NVCT

GlobeNewswire

10 months ago

Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers

Positive Signs As Multiple Insiders Buy Nuvectis Pharma Stock
NVCT

Simply Wall St.

10 months ago

Positive Signs As Multiple Insiders Buy Nuvectis Pharma Stock

NVCT

MT Newswires

10 months ago

Nuvectis Pharma's NXP800 Gets US FDA Orphan Drug Designation

Nuvectis Pharma, Inc. Reports Second Quarter 2024 Financial Results and Business Highlights
NVCT

GlobeNewswire

a year ago

Nuvectis Pharma, Inc. Reports Second Quarter 2024 Financial Results and Business Highlights

Insiders hold 65% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and they've been buying recently
NVCT

Simply Wall St.

a year ago

Insiders hold 65% of Nuvectis Pharma, Inc. (NASDAQ:NVCT), and they've been buying recently

Italian energy company targets Britain for fleet of 20 mini-nukes
NVCT

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
NVCT

Motley Fool

a year ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North
NVCT

AFP

a year ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss
NVCT

Simply Wall St.

a year ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations
NVCT

Simply Wall St.

a year ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns
NVCT

Simply Wall St.

a year ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
NVCT

Simply Wall St.

a year ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled
NVCT

Motley Fool

a year ago

3 Mistakes That Can Get Your Costco Membership Canceled

Wall Street Analysts See a 229.34% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?
NVCT

Zacks

a year ago

Wall Street Analysts See a 229.34% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?

Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
NVCT

GlobeNewswire

a year ago

Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference

NVCT

GuruFocus.com

a year ago

Nuvectis Pharma Inc Reports Q1 2024 Financial Outcomes

Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
NVCT

GlobeNewswire

a year ago

Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights

Is Nuvectis Pharma (NASDAQ:NVCT) In A Good Position To Deliver On Growth Plans?
NVCT

Simply Wall St.

a year ago

Is Nuvectis Pharma (NASDAQ:NVCT) In A Good Position To Deliver On Growth Plans?

Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
NVCT

GlobeNewswire

a year ago

Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines

Insider Buys Additional US$51k In Nuvectis Pharma Stock
NVCT

Simply Wall St.

a year ago

Insider Buys Additional US$51k In Nuvectis Pharma Stock

Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting
NVCT

GlobeNewswire

a year ago

Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting

Nuvectis Pharma to Present at the 36th Annual Roth Conference
NVCT

GlobeNewswire

a year ago

Nuvectis Pharma to Present at the 36th Annual Roth Conference

Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer
NVCT

GlobeNewswire

a year ago

Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer

NVCT

GuruFocus.com

a year ago

Nuvectis Pharma Inc (NVCT) Reports Increased Net Loss in FY 2023 Despite Clinical Progress

Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights
NVCT

GlobeNewswire

a year ago

Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights

Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders have significant skin in the game with 67% ownership
NVCT

Simply Wall St.

a year ago

Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders have significant skin in the game with 67% ownership

Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
NVCT

GlobeNewswire

a year ago

Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences

Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
NVCT

GlobeNewswire

a year ago

Nuvectis Pharma Announces Participation at Upcoming Investor Conferences

Investors in ESSA Bancorp (NASDAQ:ESSA) have seen respectable returns of 54% over the past three years
NVCT

Simply Wall St.

a year ago

Investors in ESSA Bancorp (NASDAQ:ESSA) have seen respectable returns of 54% over the past three years

Nukkleus Appoints C. Derek Campbell to Board of Directors, Bolstering its Growing Footprint in Emerging Markets
NVCT

Business Wire

a year ago

Nukkleus Appoints C. Derek Campbell to Board of Directors, Bolstering its Growing Footprint in Emerging Markets

NaaS Technology's Full Portfolio of Charging Pile Products Obtained CE Certification from the European Union
NVCT

PR Newswire

a year ago

NaaS Technology's Full Portfolio of Charging Pile Products Obtained CE Certification from the European Union

NVCT

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/25/2024

ISG to Publish Report Assessing eMobility Services and Solutions Providers
NVCT

Business Wire

a year ago

ISG to Publish Report Assessing eMobility Services and Solutions Providers

Promethean introduces new game-changing whiteboard app at FETC 2024
NVCT

PR Newswire

a year ago

Promethean introduces new game-changing whiteboard app at FETC 2024

Favourable Signals For Hamilton Beach Brands Holding: Numerous Insiders Acquired Stock
NVCT

Simply Wall St.

a year ago

Favourable Signals For Hamilton Beach Brands Holding: Numerous Insiders Acquired Stock

Quantum-Si Introduces World’s First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor
NVCT

Business Wire

a year ago

Quantum-Si Introduces World’s First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor

ePlus Joins U.S. Chamber of Commerce
NVCT

PR Newswire

a year ago

ePlus Joins U.S. Chamber of Commerce

10 Dividend Aristocrats That Slashed Their Dividends
NVCT

Insider Monkey

a year ago

10 Dividend Aristocrats That Slashed Their Dividends

What Makes FinWise Bancorp (FINW) a Good Fit for 'Trend Investing'
NVCT

Zacks

a year ago

What Makes FinWise Bancorp (FINW) a Good Fit for 'Trend Investing'

RBB Bancorp to Report Fourth Quarter and Fiscal Year 2023 Financial Results
NVCT

Business Wire

a year ago

RBB Bancorp to Report Fourth Quarter and Fiscal Year 2023 Financial Results

The Outset Launches at QVC
NVCT

PR Newswire

a year ago

The Outset Launches at QVC

NVCT

Business Wire

a year ago

Southland Awarded RFK Bridge Rehab & Other New Projects Totaling $470 Million

Nuvectis Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
NVCT

GlobeNewswire

a year ago

Nuvectis Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Can Mixed Fundamentals Have A Negative Impact on Hamilton Beach Brands Holding Company (NYSE:HBB) Current Share Price Momentum?
NVCT

Simply Wall St.

2 years ago

Can Mixed Fundamentals Have A Negative Impact on Hamilton Beach Brands Holding Company (NYSE:HBB) Current Share Price Momentum?

With 50% ownership of the shares, Angel Oak Mortgage REIT, Inc. (NYSE:AOMR) is heavily dominated by institutional owners
NVCT

Simply Wall St.

2 years ago

With 50% ownership of the shares, Angel Oak Mortgage REIT, Inc. (NYSE:AOMR) is heavily dominated by institutional owners

NVCT

Business Wire

2 years ago

Templeton Dragon Fund, Inc. ("TDF") Announces Final Results of Tender Offer

Newegg Announces Q3 2023 Results
NVCT

Business Wire

2 years ago

Newegg Announces Q3 2023 Results

NVCT

Business Wire

2 years ago

Templeton Dragon Fund, Inc. ("TDF") Announces Expiration of Self-Tender Offer

EPIX: Initial Data from Combination Trial of Masofaniten and Enzalutamide Expected in 2024…
NVCT

Zacks Small Cap Research

2 years ago

EPIX: Initial Data from Combination Trial of Masofaniten and Enzalutamide Expected in 2024…

XAI Octagon Floating Rate & Alternative Income Term Trust Adjourns Special Meeting of Shareholders to Permit Further Solicitation of Proxies
NVCT

Business Wire

2 years ago

XAI Octagon Floating Rate & Alternative Income Term Trust Adjourns Special Meeting of Shareholders to Permit Further Solicitation of Proxies

23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts
NVCT

GlobeNewswire

2 years ago

23andMe announces further expansion of 23ME-00610 Phase 1/2a clinical trial in advanced neuroendocrine and ovarian cancer patient cohorts

Nuvectis Pharma, Inc. Announces a Collaboration with Mayo Clinic to Evaluate NXP800 in an Investigator-Sponsored Clinical Trial in Cholangiocarcinoma
NVCT

GlobeNewswire

2 years ago

Nuvectis Pharma, Inc. Announces a Collaboration with Mayo Clinic to Evaluate NXP800 in an Investigator-Sponsored Clinical Trial in Cholangiocarcinoma

ChoiceOne Bank Announces Newly Redesigned, Interactive Website
NVCT

PR Newswire

2 years ago

ChoiceOne Bank Announces Newly Redesigned, Interactive Website

The Tile Shop Partners With Kelli Fontana on “Classic, Bold and Whimsical” Debut Tile Collection
NVCT

GlobeNewswire

2 years ago

The Tile Shop Partners With Kelli Fontana on “Classic, Bold and Whimsical” Debut Tile Collection

Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors
NVCT

GlobeNewswire

2 years ago

Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors

When To Sell Growth Stocks: Why This Rule Worked Like Magic For This Small-Cap Leader
NVCT

Investor's Business Daily

2 years ago

When To Sell Growth Stocks: Why This Rule Worked Like Magic For This Small-Cap Leader

Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing
NVCT

GlobeNewswire

2 years ago

Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing

James River Names William “Bill” Bowman as President and Chief Executive Officer of Specialty Admitted Insurance Segment
NVCT

GlobeNewswire

2 years ago

James River Names William “Bill” Bowman as President and Chief Executive Officer of Specialty Admitted Insurance Segment

OFG Bancorp (OFG) Hit a 52 Week High, Can the Run Continue?
NVCT

Zacks

2 years ago

OFG Bancorp (OFG) Hit a 52 Week High, Can the Run Continue?

Spark I Acquisition Corporation (NASDAQ:SPKL) stock most popular amongst individual investors who own 55%, while private equity firms hold 39%
NVCT

Simply Wall St.

2 years ago

Spark I Acquisition Corporation (NASDAQ:SPKL) stock most popular amongst individual investors who own 55%, while private equity firms hold 39%

Should You Invest in Kingsway Financial Services (KFS)?
NVCT

Insider Monkey

2 years ago

Should You Invest in Kingsway Financial Services (KFS)?

Nuvectis Pharma Insiders Added US$3.75m Of Stock To Their Holdings
NVCT

Simply Wall St.

2 years ago

Nuvectis Pharma Insiders Added US$3.75m Of Stock To Their Holdings

NVCT

Business Wire

2 years ago

Templeton Dragon Fund, Inc. ("TDF") Commences Self-Tender Offer for up to 25% of Its Common Shares

Share on Social Networks: